ci 988 has been researched along with Carcinoma, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howes, LG; Morris, DL; Romani, R | 1 |
1 other study(ies) available for ci 988 and Carcinoma, Anaplastic
Article | Year |
---|---|
Dose dependent in vivo inhibition of human colorectal cancer (LoVo) by the gastrin receptor antagonist, CI-988.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Division; Colorectal Neoplasms; Dose-Response Relationship, Drug; Humans; Indoles; Male; Meglumine; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Cholecystokinin; Tumor Cells, Cultured | 1996 |